Publicaciones en colaboración con investigadores/as de Imperial College London (9)

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

2022

  1. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

2016

  1. Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum

    Hepatology, Vol. 63, Núm. 4, pp. 1287-1298

2013

  1. Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term

    Placenta, Vol. 34, Núm. 9, pp. 810-816

  2. Maternal cholestasis during pregnancy programs metabolic disease in offspring

    Journal of Clinical Investigation, Vol. 123, Núm. 7, pp. 3172-3181

2011

  1. Characterisation of the nuclear receptors FXR, PXR and CAR in normal and cholestatic placenta

    Placenta, Vol. 32, Núm. 7, pp. 535-537

2010

  1. Inhibition of Na+-taurocholate co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites

    Journal of Biological Chemistry, Vol. 285, Núm. 22, pp. 16504-16512

2008

  1. The antiviral activities of artemisinin and artesunate

    Clinical Infectious Diseases, Vol. 47, Núm. 6, pp. 804-811

2007

  1. Expression in Human Trophoblast and Choriocarcinoma Cell Lines, BeWo, Jeg-3 and JAr of Genes Involved in the Hepatobiliary-like Excretory Function of the Placenta

    Placenta, Vol. 28, Núm. 2-3, pp. 107-117